This whitepaper explores the properties and performance of second-generation HPMC capsules, Capsugel® Vcaps® Plus capsules, compared with traditional hard gelatin capsules (HGCs). Experts present findings from both in vitro dissolution testing and an in vivo bioequivalence study evaluating identical drug formulations delivered in Vcaps® Plus capsules and HGCs, offering valuable insights for formulation scientists evaluating capsule selection and product development strategies.

By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.